MX9800026A - Preparacion farmaceutica combinada, equipo y metodo para anticoncepcion hormonal. - Google Patents

Preparacion farmaceutica combinada, equipo y metodo para anticoncepcion hormonal.

Info

Publication number
MX9800026A
MX9800026A MX9800026A MX9800026A MX9800026A MX 9800026 A MX9800026 A MX 9800026A MX 9800026 A MX9800026 A MX 9800026A MX 9800026 A MX9800026 A MX 9800026A MX 9800026 A MX9800026 A MX 9800026A
Authority
MX
Mexico
Prior art keywords
egg
yolk
whole
manufacturing
dietary cholesterol
Prior art date
Application number
MX9800026A
Other languages
English (en)
Inventor
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9800026A publication Critical patent/MX9800026A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Surgical Instruments (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invencion se relaciona a una preparacion farmacéutica combinada de dos etapas para anticoncepcion hormonal que contiene por lo menos 30 dosis diarias. La sustancia activa hormonal en la primera etapa es una combinacion de una preparacion de estrogeno y una preparacion de gestágeno en una forma de etapa individual en una cantidad por lo menos suficiente para inhibir la ovulacion. En la segunda etapa, la sustancia activa hormonal es una preparacion solamente desestrogeno. La primera etapa comprende no menos de 25 y no más de 77 dosis diarias, el numero total de unidades diarias que es igual al numero total de días del ciclo deseado, es decir, por lo menos 30 y no más de 84 días. Puede hacerse disponible la preparacion combinada, es por ejemplo, un empaque mensual y es utilizado para controlar la fertilidad en mujeres. Esta reduce a un mínimo el contenido de estrogeno en cada dosis individual y también tiene un contenido total hormonal bajo para el ciclo de dosificacion, mientras que asegura una alta confiabilidad anticonceptiva, baja incidencia del desarrollo del folículo, excelente control del ciclo y prevencion confiable del sangrado intercíclico menstrual y efectos laterales no deseados.
MX9800026A 1995-06-28 1996-06-27 Preparacion farmaceutica combinada, equipo y metodo para anticoncepcion hormonal. MX9800026A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19525017A DE19525017A1 (de) 1995-06-28 1995-06-28 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
PCT/DE1996/001192 WO1997001342A1 (de) 1995-06-28 1996-06-27 Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption

Publications (1)

Publication Number Publication Date
MX9800026A true MX9800026A (es) 1998-03-31

Family

ID=7766408

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800026A MX9800026A (es) 1995-06-28 1996-06-27 Preparacion farmaceutica combinada, equipo y metodo para anticoncepcion hormonal.

Country Status (22)

Country Link
US (2) US6027749A (es)
EP (1) EP0835114B1 (es)
JP (1) JPH11508538A (es)
CN (1) CN1137690C (es)
AT (1) ATE239483T1 (es)
AU (1) AU6352896A (es)
BR (1) BR9609317A (es)
CA (1) CA2225724C (es)
CZ (1) CZ420597A3 (es)
DE (2) DE19525017A1 (es)
DK (1) DK0835114T3 (es)
ES (1) ES2199293T3 (es)
HU (1) HU223976B1 (es)
IL (1) IL122109A (es)
MX (1) MX9800026A (es)
NO (1) NO317671B1 (es)
NZ (1) NZ312081A (es)
PT (1) PT835114E (es)
RU (1) RU98101254A (es)
SK (1) SK178097A3 (es)
WO (1) WO1997001342A1 (es)
ZA (1) ZA965547B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
ATE271386T1 (de) * 1996-07-26 2004-08-15 Wyeth Corp Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
WO2004112797A1 (en) * 2003-06-25 2004-12-29 Schering Ag Hormone replacement- and depression therapy comprising dienogest
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
BRPI0414945A (pt) * 2003-10-01 2006-11-07 Janssen Pharmaceutica Nv regimes contraceptivos trifásicos estendidos
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102004026670A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
DE502006000771D1 (de) * 2005-02-15 2008-06-26 Bayer Schering Pharma Ag Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
US20070072836A1 (en) * 2005-02-15 2007-03-29 Sabine Fricke Solid peroral contraceptive preparations
US20060205701A1 (en) * 2005-02-15 2006-09-14 Sabine Fricke Solid peroral contraceptive preparations
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US9198876B2 (en) * 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CA2740005C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (en) * 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
AU2016282863B2 (en) * 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5320850A (en) 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344405C2 (de) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
NO317671B1 (no) 2004-11-29
NZ312081A (en) 1999-04-29
US6312722B1 (en) 2001-11-06
CN1189101A (zh) 1998-07-29
JPH11508538A (ja) 1999-07-27
WO1997001342A1 (de) 1997-01-16
ZA965547B (en) 1997-01-27
CZ420597A3 (cs) 1998-03-18
US6027749A (en) 2000-02-22
HU223976B1 (hu) 2005-03-29
IL122109A0 (en) 1998-04-05
CA2225724C (en) 2008-01-15
DK0835114T3 (da) 2003-09-01
IL122109A (en) 2006-07-05
ATE239483T1 (de) 2003-05-15
BR9609317A (pt) 1999-07-06
SK178097A3 (en) 1998-05-06
NO976067D0 (no) 1997-12-23
RU98101254A (ru) 2000-01-27
NO976067L (no) 1998-02-27
DE59610425D1 (de) 2003-06-12
CA2225724A1 (en) 1997-01-16
HUP9900252A2 (hu) 1999-05-28
EP0835114B1 (de) 2003-05-07
DE19525017A1 (de) 1997-01-02
HUP9900252A3 (en) 2001-09-28
PT835114E (pt) 2003-09-30
ES2199293T3 (es) 2004-02-16
CN1137690C (zh) 2004-02-11
AU6352896A (en) 1997-01-30
EP0835114A1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
MX9800026A (es) Preparacion farmaceutica combinada, equipo y metodo para anticoncepcion hormonal.
WO1999012580A3 (en) Waste treatment control system
IL118122A (en) Textured protein food products
ZA955051B (en) Process and plant for the production of gaseous oxygen under pressure
EP0684123A3 (en) Stretched polychlorotrifluoroethylene film, process for its manufacture and use of the film for packaging a product.
MX9800102A (es) Proceso para la modificacion de gluten de trigo.
UA32542C2 (uk) Спосіб безперервного зволоження сипких харчових продуктів і кормів та пристрій для його здійснення
GB9411664D0 (en) Improvements in and relating to the production of food products
WO2003025101A3 (en) Waste treatment
GB9411694D0 (en) Improvements in and relating to the production of food products
HUP9702027A3 (en) Microcapsulated polymer product and process for producing thereof, use of the microcapsulated polymer product
HK1002915A1 (en) Plant gum material and use thereof in food products
JPS57206608A (en) Production of gamma-globulin for intravenous injection
ATE199379T1 (de) Verfahren zur verbesserung der verwert- und verarbeitbarkeit von guar-endosperm und die danach erhaltenen erzeugnisse
ES2116937A1 (es) Procedimiento de obtencion de peptonas vegetales de alto grado de hidrolisis y sus aplicaciones.
PL296843A1 (en) Method of dewatering products, apparatus therefor and product of reduced water content
KR960702756A (ko) 방향성 물질을 확산시키는 방법 (metho for diffusing an odoriferous substance)
KR930019129A (ko) 무취화 마늘의 제조방법
GB9503081D0 (en) Improvements in and relating to the production of food products
JPS5452791A (en) Preparation of d-alpha-amino acid
AUPN527895A0 (en) Product and process relating to albicidin detoxification enzyme
EP0731172A3 (en) Process for the preparation of galactosyltrehalose and food containing it
UA10030C2 (uk) Спосіб і пристрій для термічної обробки м'ясних і рибних продуктів
ES2148791T3 (es) Procedimiento para la produccion de azometinas y alfa-haloacetanilidas.
WO1995033456A3 (en) Reducing intraocular pressure using aryloxy- and aryl-acetic acids